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H I G H L I G H T S  
• 10 cycles of washing or 5 washing followed by 5 autoclaving cycles have been tested. 
• Medical masks can be reused up to 10 times with a cleaning method between each use. 
• Masks retain their breathability/filtration capability after 10 cycles of cleaning. 
• Treated masks lack of their CE marking but are qualified with S76-001 AFNOR norm. 
• Pragmatic guidance will allow to generate 10 times less plastic in the environment.  
A R T I C L E  I N F O   
Handling Editor: Y Yeomin Yoon  
A B S T R A C T   
The need for personal protective equipment increased exponentially in response to the Covid-19 pandemic. To 
cope with the mask shortage during springtime 2020, a French consortium was created to find ways to reuse 
medical and respiratory masks in healthcare departments. The consortium addressed the complex context of the 
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balance between cleaning medical masks in a way that maintains their safety and functionality for reuse, with the 
environmental advantage to manage medical disposable waste despite the current mask designation as single-use 
by the regulatory frameworks. We report a Workflow that provides a quantitative basis to determine the safety 
and efficacy of a medical mask that is decontaminated for reuse. The type IIR polypropylene medical masks can 
be washed up to 10 times, washed 5 times and autoclaved 5 times, or washed then sterilized with radiations or 
ethylene oxide, without any degradation of their filtration or breathability properties. There is loss of the anti- 
projection properties. The Workflow rendered the medical masks to comply to the AFNOR S76-001 standard as 
“type 1 non-sanitory usage masks”. This qualification gives a legal status to the Workflow-treated masks and 
allows recommendation for the reuse of washed medical masks by the general population, with the significant 
public health advantage of providing better protection than cloth-tissue masks. Additionally, such a legal status 
provides a basis to perform a clinical trial to test the masks in real conditions, with full compliance with EN 
14683 norm, for collective reuse. The rational reuse of medical mask and their end-of-life management is critical, 
particularly in pandemic periods when decisive turns can be taken. The reuse of masks in the general population, 
in industries, or in hospitals (but not for surgery) has significant advantages for the management of waste 
without degrading the safety of individuals wearing reused masks.   
1. Introduction 
The healthcare sector has a high utilisation of single-use disposables 
and thus generates a large amount of waste, albeit that 20–25% of which 
is recyclable plastic material (Campion, et al., 2015; Byeong Kyu, 2002; 
Kane, 2018). Medical masks are medical-use disposables and have 
become essential for usage by the general community due to the need to 
control the Covid-19 pandemic. Governments around the world quickly 
mandated that wearing a mask was compulsory in public spaces. This 
rapidly increased the demand for respiratory and surgical masks, lead-
ing to mask shortages that forced authorities to change their policies and 
restrict initially the use of surgical masks to healthcare workers (HCW). 
At the beginning of the pandemic, one or two mask per day per person 
were distributed instead of following the normal practice of changing 
the mask for each person between each medical procedure. The conse-
quences for that pattern of usage led to a reduced breathability in the 
masks and the possibility for germs to translocate. Indeed, sub-optimal 
recycling procedures consisted of disinfection without any cleaning 
step (Liao et al., 2020; Ibáñez-Cervantes et al., 2020; Cai and Floyd, 
2020; Cheng et al., 2020; Bernard et al., 2020). 
Concurrent with the enhanced needs for HCW, the general commu-
nity was mandated to have face coverings to combat the spread of Covid- 
19. Since the use of medical masks was reserved initially for HCW, cloth- 
tissue mask face coverings were developed as a last-resort interim so-
lution for the general community. However, their level of protection is at 
least 5 times less than medical masks, simply due to the structure and 
material used for manufacturing and the light-touch regulatory envi-
ronment (SI-0). 
The Covid-19 pandemic is caused by the community transmission of 
the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) 
virus. The 60–140 nm virus (Zhu et al., 2020) travels in micron-size 
water droplets (Tang et al., 2021; Wei et al., 2021) and can also be in-
fectious in the form of aerosols. However, the larger amount of virus is 
found in large particles (Wei et al., 2021). 
The Type IIR medical masks are disposable medical devices 
following standards: NF EN 14683:2019 in Europe, ASTM F2100-19 
level 1,2,3 in USA, and YY/T 0969–2013 and YY 0469–2011 in China 
(SI-0). Type IIR medical masks are made from at least 3 layers of non- 
woven polypropylene, with 2 layers (inward-facing and outward- 
facing) spun bond (S) polypropylene, between which a melt blown 
(M) higher filtration layer of polypropylene is disposed. Those 3 “SMS” 
layers provide an efficient network for filtration. They are certified to 
prevent the projection of secretions from the airways of the wearer as 
they filter more than 98% of 3 μm droplets from inside to outside. They 
are certified to protect others from the wearer’s respiratory emissions. 
Nevertheless, they are used to protect the wearer from the respiratory 
emissions of others. 
Despite the health-care value of Type IIR masks, such disposable 
masks create an environmental hazard since the complete 
biodegradation of polypropylene is a very slow process that requires 
hundreds of years (Fotopoulou and Karapanagioti, 2017, Dharmaraj 
et al., 2021). Moreover, the term “disposable”, or indeed descriptions 
such as “paper masks”, reinforces the accumulation of these masks as 
litter in the environment. Such inappropriate community disposal of 
contaminated masks raises health questions, not the least of which is the 
high cost due to environmental damage. Indeed, if good-practices for 
waste management or recycling have not been established then the 
disposal of the increased number of polypropylene masks becomes a 
major, and increasing, environmental pollutant. Recent publications on 
the subject reveal an overload of the plastic waste used during the 
pandemic, as occurred in Wuhan’s hospital, producing 200 tonnes of 
medical waste in one day, which has to be incinerated by mobile 
treatment facilities (Saadat et al., 2020, Silva et al., 2020; Singh et al., 
2020; Ardusso et al., 2021). The number of medical masks is roughly 
estimated between 1 and 1.3 billion per month in Italy and UK, corre-
sponding to 66 000 tonnes/year of waste (Allison et al., 2020; Prata 
et al., 2020). Furthermore, during the first pandemic episode in Europe, 
the price of medical masks was multiplied by at least a factor 10, 
including the price increase of the raw material and the transport cost. 
Here we take a systematic and experimental approach to the question 
of whether Type IIR masks can be reused. There is a complex context for 
this question that includes the balance between cleaning medical masks 
in a way that maintains their safety and functionality for reuse, with the 
environmental advantage to manage medical disposable waste despite 
the current mask designation as single-use by the regulatory frame-
works. Our approach is to design a Workflow for cleaning masks that is 
based on elements from existing Standards to ensure the safety and 
function of reused medical masks. Our Workflow provides data upon 
which to base a possible revision of the regulatory framework for Type 
IIR masks. Such an evidence-based Workflow, designed to maintain the 
efficacy of medical masks, then provides a rational basis to respond to 
the needs for community protection and prevention in the face of the 
emergence of highly transmissible SARS-CoV-2 mutants or indeed the 
next virus pandemic. It also provides the basis for a possible revision of 
the regulations for the reuse of medical masks to address the significant 
broader issue of improving the sustainability of medical disposables. 
2. Materials and methods 
We designed a 8-stage Workflow to assure the safety and function-
ality of medical masks for reuse derived from existing Standards publi-
cations. The Workflow was applied to both unused (new) masks taken 
directly from the original packaging, and used masks collected from 
hospitals in Grenoble and Nancy. We anticipated the outcomes from this 
Workflow can provide quantifiable ways to determine and trace the 
reusability of medical masks. 
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2.1. Unused (new) masks 
All the new masks used in this study are type II medical face masks 
following the European standard “EN 14683+AC august 2019 Medical 
face masks - Requirements and test methods”, corresponding to ASTM 
F2100-19 (USA) and YY/T 0969–2013 (China). The properties of type 
IIR masks as defined by EN 14683+AC august 2019 are as follows:  
(i) the microbial cleanliness should be less than 30 CFU/g of mask.  
(ii) the label “II” refers to class II masks featuring a 98% bacterial 
filtration efficiency (BFE) with 3 ± 0.3 μm mean particle size. 
This FE is measured in the direction of its normal usage, i.e. from 
the wearer to the environment,  
(iii) the breathability refers to the differential pressure and should be 
lower than 40 Pa/cm2,  
(iv) the label “R” refers to a splash resistance layer protection (≥16 
kPa) against body fluid spills. 
The new unused 3 ply IIR-type masks (ref. CA 1960) were provided 
by CA diffusion to Grenoble and Nancy hospitals for all the 7 stages of 
the workflow (Fig. 1). The masks comprise non-woven fabric SMS 
(Spunbond, Meltblown, Spunbond). They contain a low amount of 
phenolic antioxidant (butylated hydroxytoluene, Irganox 1076). The 
mask fits snugly with the help of a nasal bar (pliable nose piece) and with 
ear loop elastic bands (containing elastane + polypropylene) or with 2 
flat polypropylene ties. 
In addition, ten different unused brands of masks have been tested in 
Nancy Hospital as a control for the washing cycles: CA diffusion 1931 
(II), 2015-30 Medicom (IIR), MPB-CH1 Paul Boyé (IIR), PLM.01R Aer-
okyn (IIR), Earloop LyncMed 302089 (II), Sunrise Nursing (not known), 
TD Professional 45455 (II), The Lite One Kimberly Clark (IIR), LiangYa 
DGTMYY (I), Saudel 85002 (II). 
2.2. Used masks 
A protocol was established in different departments of Grenoble 
Alpes University Hospital (CHUGA) for collection of masks between 03/ 
17/2020 and April 06, 2020, and for collection in different departments 
of Nancy University Hospital between 04/24/2020 and June 08, 2020. 
The protocol required that containers and bags dedicated to collec-
tion were placed in the different departments where HCW left their used 
masks at the end of their working day. The used masks were collected 
within specifically labelled double packaging, transported and stored in 
an appropriate place. Particular attention was paid to the protection 
conditions of the collection personnel (wearing of gowns, masks and 
strict hand hygiene). A wide range of brands was used in the hospital 
during this period and up to 9 different references of type IIR medical 
masks have been collected and tested, comprising the trademarks CA 
diffusion, Kolmi, Valmy, Euronda, Medicom, LCH Medical product, 
LyncMed and Paul Boyé. Masks with ties have been excluded. 
2.3. Workflow Stage 1: sorting and washing of the used masks 
After collection, the reusable masks have been rapidly selected under 
a laminar flow cabinet. When the guidelines were properly applied, this 
step was no more necessary and the masks were then transferred directly 
to the Hospital’s laundry and washed according to the recommendations 
of the cleaning product manufacturer. The washing step followed the 
existing classical closed-circuit of the hospital. The 2 procedures are 
summarized in the washing step procedure in SI-1 section and consist in 
a 60 ◦C washing with detergents and disinfectants solutions. 
2.4. Workflow Stage 2: sterilization  
(a) by autoclave 
The Sterility Assurance Level (SAL) of 10− 6 is the probability of 1-in- 
1-million to find a remaining living bacteria. It is frequently used for the 
last step of sterilization of implantable devices. Steam sterilization is the 
reference method for sterilizing items at the hospital and in all biology 
science departments. It follows the European regulation ISO 17665–1. 
Before autoclaving, the masks were unfolded, bundled in lots of 10 
masks, and packed in peelable see-through pouches with steam and EtO 
indicators BOP®. After sealing, the pouches were placed in the autoclave 
Advantage class B or for a treatment at 121 ◦C during 20min. The 
pouches were dried at 70 ◦C during 20min after this treatment to remove 
the condensed water inside the pouches.  
(b) by cold sterilizations 
Three types of cold sterilizations were conducted. The first two were 
beta and gamma irradiations from 20 kGy to 40 kGy. The third one was 
Fig. 1. Description of the type IIR new mask used in this study: a) Outside face of the mask b) Nasal bar out of the mask and its non-covered metallic extremity c) The 
3 layers of a polypropylene mask. 
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an EO treatment consisting in an exposition of the masks to 850 mg/L EO 
gas during 12 h at 40 ◦C and 65% relative humidity (SI-2a and -2b). 
2.5. Workflow Stage 3: analysis of microbial cleanliness 
The microbial cleanliness was verified according appendix D of EN 
14683+AC august 2019 and described in SI-3a. Briefly, 5 washed masks 
per batch were tested. Each mask was weighed, incubated in a 300 mL 
volume extraction buffer (0,1% peptone, 0,2% Tween 20, 0,5% NaCl) 
for 5min at 25 ◦C with stirring at 250 rpm. Then a volume of 100 mL of 
the extraction buffer was filtered on a 0.45 μm filter fitted into a 
filtration apparatus. Rinsing of the filtration apparatus was performed 
with an additional 5 mL of sterile extraction buffer. Then, the 0.45 μm 
filter was removed and placed on trypticase soja agar plate. Bacterial 
colony counting was performed after 3 days of incubation at 30 ◦C. The 
operation was repeated with another 100 mL of the extraction buffer for 
yeast and fungus counting. The new filter from this second filtration was 
placed on Sabouraud + chloramphenicol (BD France) plates that were 
incubated for 7 days at room temperature before counting. 
2.6. Workflow Stage 4: sporicidal claim check after washing and 
autoclave treatment 
106 Geobacillus stearothermophilus spores were inoculated on masks 
under dirty soiling conditions (SI-4a) according to norms NF T72-230/ 
231, NF EN 14347 and NF EN 13704. The spot of inoculation was 
marked using a permanent marker. The masks were left on the bench for 
24h00 and then washed according to the Workflow Stage 1 protocol, and 
autoclaved (212◦C-20min) using the Workflow Stage 2 protocol. Colony 
counting was carried out after treatment (washing or washing/auto-
claving) versus untreated samples. The marked spot was cut out (3–4 
cm2) then transferred to a 15 mL tube containing 5 mL of 2 M NaCl. The 
tubes were placed under vigorous stirring (250 rpm) for 5min at 25 ◦C 
before being filtered through a 0.45 μm filter placed on a filtration 
apparatus. Rinsing of the device was performed with an additional 5 mL 
of sterile water. The membrane was then transferred to a trypticase soja 
plate and incubated at 65 ◦C for 24 h before colony counting. 
2.7. Workflow Stage 5: particle filtration efficiency (PFE) 
BFE is the existing standard method to evaluate the resistance of a 
face mask to the penetration of a bioaerosol of Staphylococcus aureus. 
However, we have chosen to confirm and supplement the BFE mea-
surements with spectral PFE measurements for an inert di-ethyl-hexyl- 
sebacate (DEHS) liquid aerosol. The BFE and PFE techniques are com-
parable since the respective particle sizes are around 3 μm and their 
capture by a filter is the result of physical mechanisms that depend 
mainly in inertial impact (Brosseau et al., 1994, Wake et al., 1997; 
González et al., 2016). The main difference is that BFE test was 
expressed from the number of 1 μm viable bacteria contained in 3 μm 
droplets passing through the medical face mask, whereas the PFE test 
was calculated from the fractional number concentration of 3 μm vectors 
measured upstream and downstream of the mask. However, the PFE 
provides a more robust quantification of the spectral efficiency of the 
filter in capturing the inert DEHS particles since it based on optical or 
aerodynamic particle sizer techniques to count particles both upstream 
and downstream of the filter. The PFE measurements provide more 
reliable quantification of spectral efficiency of the filtering capability of 
the masks compared with microbial particle counting using 
culture-based methods (BFE).  
(a) according to NF EN 14683 
The assessment of BFE was performed according to the EN 
14683:2019 standard for the performance of medical masks and using a 
published procedure (Pourchez et al., 2021). Test specimens with a 
minimum size of 100 mm by 100 mm were cut from complete masks so 
that the test specimen included all layers of the mask. The test specimen 
of the mask material was clamped between a six-stage viable Andersen 
cascade impactor and an aerosol chamber (glass, 445 mm long and 60 
mm in external diameter). Each test specimen was conditioned in air at 
21 ± 5 ◦C and 85 ± 5% relative humidity for a period of at least 4 h to 
allow equilibration with that atmosphere prior to testing. An aerosol of 
3.0 ± 0.3 μm droplets was formed from a suspension of 3 mL at 2,000 
CFU/mL of S. aureus (ATCC 6538) using an E-Flow® mesh nebulizer 
(Pari GmbH, Starnberg, Germany) to maintain a bacterial challenge 
2200 ± 500 CFU per test with a 1min nebulization. The aerosol of 
S. aureus was introduced into the aerosol chamber and drawn through 
the mask material and the impactor under vacuum. The testing was 
performed with the inside of the medical face mask in contact with the 
airborne bacterial challenge. The FE of the mask is given by the number 
of colony forming units (CFU) passing through the medical face mask 
material expressed as a percentage of the number of CFU present in the 
challenge aerosol. The positive control reference was obtained by 
omitting the test specimen from the measurement chamber. Then, the 
BFE score for the mask, as a percentage, was calculated using the 
following formula: BFE=(C− T)/C × 100, where C is the mean of the 
total plate counts for the two positive control runs, and T is the total 
plate count for the test specimen. The testing procedure was repeated for 
at least 5 specimens of the mask.  
(b) Inert particle filtration using PFE 
The spectral PFE of the tested masks was evaluated using separate 
devices from two different French laboratories, the GEPEA Lab in Nantes 
(Génie des Procédés Environnement – Agroalimentaire, UMR 6144) and 
the LRGP Lab in Nancy (Laboratoire Réactions et Génie des Procédés, 
UMR 7274). Depending on the device that was utilised, the sample of 
medical face mask was placed in a filter holder with a filtration surface 
area of either 168 cm2 (GEPEA Lab) or 28.3 cm2 (LRGP Lab). A poly-
disperse DEHS aerosol was produced with a MAG300 Palas® generator 
diluted with filtered air for the device with the surface are of section 
168cm2, and with an AGK 2000Palas® generator diluted with com-
pressed air for the device of section 28.3cm2. The polydispersed liquid 
aerosol of DEHS generated in both experimental devices produced 
droplets between 1 μm and 3 μm to provide a comparison with the 3.0 
μm droplets generated by the aerosol chamber of the BFE tests. Filtration 
velocity was adjusted at 9.6 cm/s corresponding to the one used in the 
NF EN 14683+AC. After dilution, the fractional number concentration 
was measured upstream and downstream of the mask with respectively 
an optical counter (Welas Palas®) and an Aerodynamic Particle Sizer 
(Model 3321 TSI®). 
The fractional efficiency, efficiency for a given particle size, is 




where CN,up and CN,down are respectively the particle number concen-
tration upstream and downstream of the filter for a given DEHS droplet 
size (dp). 
The efficiency measurement was achieved from a series of 7 counts 
conducted successively upstream and downstream of the filter. Before 
each measurement, a sampling of 30 s is performed in order to purge and 
stabilize the concentration of particles in the sampling lines. These 7 
counts give three efficiency results for the same mask sample (repeat-
ability test). Efficiency measurements are conducted on three or four 
samples cut in one or two medical face masks (reproducibility test). 
2.8. Workflow Stage 6: breathability 
In accordance with the Standard NF EN 14683, the pressure drop of 
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the mask was determined at a filtration velocity of 27.2 cm/s. This 
differential pressure should be divided by the standard filtration area of 
4.9 cm2 before being compared with the normative values of <40 Pa/ 
cm2 for type I and II, and <60 Pa/cm2 for type IIR. 
2.9. Workflow Stage 7: projection resistance 
For these measurement the masks, the experimental set-ups pro-
posed by ISO 22609:2004 standard were adapted to the materials and 
equipment available in the labs. The experimental devices were vali-
dated by monitoring the corresponding injection pressure and injection 
duration with reference to those given by the ISO norm table. The 
projection resistance tests were performed under the conditions 
described by the ISO Standard, at a blood ejection rate of 550 cm/s 
corresponding to a blood pressure of 16 kPa. The tests were repeated 
once for each type of mask under the same conditions. To be fully 
compliant with ISO 22609, nearly 30 tests should be performed for each 
type of mask, which is obviously not possible in the current context (SI- 
5a and -5b). 
2.10. Workflow Stage 8: chemical and structural characterizations 
Fourier Transform Infrared (FTIR) spectroscopy and Scanning Elec-
tron Microscopy (SEM) experiments were conducted to complete the 
workflow. Each protocol is described in SI-8a and -8b. 
3. Results 
3.1. Cleanliness after workflow: macroscopic inspection of the washed 
masks 
For this stage of the Workflow an initial mask sorting step was per-
formed before the washing step. Some masks were excluded from the 
washing because they were too dirty, mostly due to make-up smears 
(around 3–4% of the total collection). Masks with low quantity of 
makeup were well cleaned. We’ve noticed during this study, that around 
1% of the collected masks were repaired with a staple, which high-
lighted the shortage of masks during the collection periods. Up to 10 
washing/drying cycles did not modify the appearance of the mask. 
The visual inspection of the new CA diffusion 1960 masks after 
washing did not show any significant structural defect, apart from 
broken elastic ear-loops (5–7% of the masks) that always at the welding 
spot between the mask and the elastic band. Minor rust spots are 
appearing on 25% of the mask at the two ends of the nasal bar after 2 
washing cycles. Those rust spots do not have any adverse effect on the 
face mask fitting. 
Similar results were found with the 9 used collected different brands 
in Grenoble and 10 different brands in Nancy. All the masks look clean, 
without any dimensional change, 5% of the mask had a broken elastic 
ear-loop, rust spots were observed on 1/3 of the masks (Fig. 2a). We 
have noted that for 50% of the Euronda masks the nasal bar was able to 
dislodge from the sheath on the mask. 
3.2. Cleanliness after workflow: microbial inspection of used masks 
We applied to our washed masks the same tests applied for new 
fabricated masks in accordance with NF EN 14683. For this, we 
extracted randomly 5 masks from 4 different washing batches and 
measured the number of bacterial and fungal CFU present on each mask. 
The results (SI-3b) met expectations as the total measured CFU is 5 times 
less than the limit described in the norm (≤ 30 CFU/g). Nonetheless, the 
variability from one mask to another is large (Fig. 2c) with 1/3 of the 
mask containing between 6 and 9 CFU/g and 1 mask containing 29 CFU, 
which corresponds to the maximum allowed by the norm. 
3.3. Cleanliness after workflow: masks washed in dirty conditions 
Washing tests performed with 40 new masks in the dirty conditions 
recommended by the norms (SI-4a). Each new mask was soiled with 100 
μL inoculum of the “dirty suspension” and then dried before the treat-
ment (Fig. 2b). The blood stain was completely cleaned by the washing 
step. It may be noted that the permanent marker used to mark the spot is 
still present. Thus, the permanent marking of a used mask ensures easily 
a good traceability during all processes, and particularly during the 
tread life of a recycled mask. 
We have also conducted an experiment to consider the worst possible 
case of spotting 106 spores of G. stearothermophilus in dirty conditions 
onto 5 new masks. A 4 log10-fold reduction of spores was observed after 
washing. Spores are considered as the most resistant living organisms 
and are a good standard for a quality control. The SAL of 10− 6 was 
largely achieved with a following sterilization step, for example by 
autoclaving the masks 20min at 121 ◦C (Fig. 2d and SI-4b). 
Fig. 2. a) Rust spots at the extremity of the nasal bar of a mask b) Mask (before/after) washed in dirty conditions c) Microbial distribution after a washing step d) 
Geobacillus stearothermophilus count after treatment in dirty conditions. 
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3.4. FE after workflow 
The results of BFE (mean and spectral) and spectral PFE are pre-
sented in Table 1 and SI-6a,b,c for the treatments of new masks “CA 
diffusion 1960”. Several batches comprising at least 5 masks were first 
treated, in particular washing cycles, washing cycles followed by auto-
claving cycles and washing/alternative sterilizing cycles. The first line of 
the table (L201, L203, L204, and L327) corresponds to the untreated 
masks. Regardless of the treatment used, the filtration properties were 
preserved as quantified by the mean BFE greater than 99.6% ± 0.3 
according to the NF EN 14683 standard (SI-0). These results indicate 
that those treated face masks passed the standard thresholds for filtra-
tion efficiencies, despite the possibility that the 3 layers of the masks 
could have separated during washing. 
The spectral filtration efficiencies obtained by CFU counting for the 
BFE and by optical counting for PFE (Table 1) comply with the approved 
standards for particle size greater than 1 μm. For 3 μm particles, spectral 
BFE and PFE are always higher than 99.0% (%CFU or %OPTICAL) indi-
cating that the different treatment processes (until 3 or 10 cycles ac-
cording to the treatment) do not seem to deteriorate the protective 
performance of those face masks. Alternative cold sterilization proced-
ures, i.e radiations and EO treatment, are described in SI-2 section and in 
a preliminary IAEA report (Cortella et al., 2020). No degradation of PP 
and EO residues were found after treatment. Some minor chemical 
modifications, were measured mostly due to the presence of 
anti-oxidants in new masks. 
The differences between the two sets of spectral PFE measurement 
can be explained by the use of two different experimental devices 
inducing differences in (i) the filtration section which a ratio of 6 (168 
and 28.3 cm2), (ii) distribution, and concentration of the liquid particle 
size of the DEHS generated by the two systems, (iii) the particle counting 
systems, which are based on two different principles of particle size 
measurements (optical counter based on light diffraction and aero-
dynamic sizer based on time of flight). 
For submicron-sized particles (impaction plate collecting size frac-
tion between 1.1 and 0.65 μm for BFE, and particle size of 1, 0.67 and 
0.3 μm for PFE), the BFE and PFE values are different but show the same 
tendency for FE to decrease with particle size and the influence of the 
treatment processes, which altered the efficiency for those fine particles 
but without degrading the mean BFE values. We have noticed that this 
loss of efficiency for submicron-sized particles is effective after the first 
wash and stabilized at the same level after several washes, regardless of 
the washing process (SI-6b). At submicron-size, the filtration involves 
other mechanisms than inertial impact that can particularly include 
electrostatic mechanisms. This electret effect (Lin et al., 2017; Hossain 
et al., 2020) of the polypropylene fibres is permanently destroyed during 
the first wash because the washing agents bind to the surface and cannot 
be removed. This effect can be mimicked by the rinsing of a new mask in 
isopropanol (SI-6c). Results show that the discharging of a mask leads to 
the same spectral collection efficiencies than those of a washed mask, 
confirming the loss of electret effect as a result of the first washing 
cycles. 
Used medical masks come from hospital departments and consist of 9 
different reference brands (Table 2). They have undergone 5 washing 
cycles followed by 5 autoclave cycles. After sterilization and washing, 
the filtration properties were conserved for all the samples, with a 
minimum mean BFE of 98.2% ± 1.2 for the sample with the lowest 
filtration performance, which is above the NF EN 14683 standard 
threshold. The comparison of spectral BFE and spectral PFE (Table 2 and 
SI-6d) confirms the good protection performances of the used masks 
after 5 decontamination procedures for particle sizes higher than 2 μm 
(BFE>99.6%CFU and PFE>97.2%OPTICAL). Even if some differences can 
be observed between these 9 reference brands, results show a preser-
vation of the spectral BFE and PFE for particle size higher than 2 μm 
whatever the mask. A significant decrease of spectral efficiencies (both 
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though the BFE shows a good filtration performance of greater than 
91.2% for submicron particle sizes in the range 0.65 μm–1.1 μm. 
To check the influence of a hole or a notch that can occur accidently 
in the mask during the recycling process, we deliberately damaged a 
series of mask after one use/washing/autoclave cycle and tested their 
FE. Holes were created in the center of the masks in two ways. The first 
was to pierce the mask material with a blunt cylindrical tool such as a 
Phillips screwdriver to create holes from 1 to 5 mm. The second was to 
use a razor blade to make cuts of 7 and 10 mm. Those techniques 
punctured the mask material and created a rough-sided hole from 1 to 5 
mm or a clean side cut of 7 and 10 mm without explicit removal of the 
material within the confines of the punctured hole. Indeed, an accidental 
explicit removal of material with a hole puncher is highly unlikely 
compared to a tear (as we have simulated with the razor blade cuts). The 
figure SI-6e shows results of PFE measurements performed on a medical 
mask (L101) and on the same mask with holes of different sizes on the 
center part of the mask face (L102 with hole of respectively 1, 2, 3, 4, 5 
mm and cuts of 7 and 10 mm size). Due to the multi layer media 
constituting the mask, even in the case of big holes (>3 mm) no sig-
nificant influence is observed for spectral efficiency for particle diameter 
higher than 1 μm (apart for the test performed with a hole of 2 mm for 
which a slight decrease of PFE is observed). For particle sizes lower than 
1 μm, the presence of holes in the mask can contribute to a slight 
decrease of the spectral efficiency compared with the mask without any 
hole. 
3.5. Breathability after workflow 
The breathability performances (resistance to air flow) were not 
significantly affected regardless of the particular decontamination pro-
cess. When compared with untreated masks, breathability values 
remained within the variability range of measurements made on the 
untreated masks (variation due to the intrinsic local heterogeneity of the 
fibrous structure composing the masks) and were always under 
normative values, i.e. of 40 Pa/cm2 for a type I or II and 60 Pa/cm2 for a 
type IIR. The Mann-Whitney U test (Spiegel and Stephens, 2008), a 
non-parametric statistical test applied to data, confirmed that the 
breathability of treated masks (regardless of the type of treatment) is not 
significantly different from that of the untreated masks. Thus, we can 
conclude that the sterilization and washing cycles do not alter the 
structure of the non-woven media. 
3.6. Projection resistance after workflow 
The projection resistance (“R” function) was tested on an experi-
mental set-up aiming to reproduce the test conditions recommended by 
ISO 22609:2004 Standard. This set-up was developed, validated and 
implemented on new or washed masks with a synthetic blood formu-
lation. The “R” function was lost after a few washing steps, regardless of 
the particular brand of type IIR mask. It appears that washing changes 
the surface properties of the outer layer of a washed mask which leads to 
the loss of the protective function (SI-5c). The projection resistance is 
not maintained after recycling, which means that medical team working 
in an operating room should not wear washed IIR masks. 
3.7. Chemical and structural characterizations 
The two broad ranges from 2835 to 2952 cm− 1 and from 1165 to 
1452 cm− 1 of FTIR spectrum are characteristics of polypropylene. The 
FTIR analysis does not reveal significant oxidation processes after 
cleaning (SI-8a). 
SEM images of treated masks are presented in SI-8b. No significant 
morphological modifications were noticed, except for MPB-CH1 melt- 
blown layer containing thinner fibres (SI-8b). However, these modifi-
cations do not impact the filtration that remains very high (Table 2). 
Table 2 
Filtration efficiency of used mask after 5 washing steps followed by 5 autoclaving steps. The mean BFE corresponding to the NF EN 14683 AC norm is in bold format. * 





Mask brand Bacterial 
filtration 
efficiency 
norm NF EN 
14683 AC 
fractional bacterial filtration efficiency norm NF 
EN 14683 AC 




















100.00% 100.00% 99.57% 73.33% 99.88% 98.91% 98.6% 94.89% 68.72% 39.54% 









44.6%* – - - 




99.92% 100.00% 93.92% 46.67% 99.99% 98.9% 97.5% 82.41% 45.92% 28.3% 





99.93% 99.87% 95.30% 18.00% 99.39% 97.22% 93.45% 71.47% 37.69% 25.85% 




100.00% 99.91% 95.54% 3.16% 99.99% 97.78% 94.98% 74.10% 40.11% 24.63% 
L106 10 Used Valmy 99.82 ± 
0.07% 
100.00% 100.00% 98.63% 88.00% 88.38% 87.48% 86.32% 72.99% 37.51% 24.01% 





100.00% 99.97% 98.22% 20.00% 98.30% 98.62% 97.24% 80.29% 42.38% 25.74% 





100.00% 100.00% 98.19% 42.86% 98.25% 93.40% 92.09% 75.16% 36.00% 17.81% 




100.00% 100.00% 98.75% 73.33% 99.99% 99.91% 99.66% 94.23% 61.40% 33.14% 





100.00% 99.96% 99.20% 91.25% 99.99% 99.96% 99.94% 96.14% 66.22% 36.53%  
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4. Discussion 
4.1. Cleanliness, filtration and breathability of type II medical masks 
remain compatible with EN14683 after up to ten cycles of washing cycles 
at 60 ◦C with detergent 
Reuse must ensure the conservation of the paramount properties of 
the mask. We have proven that the process of washing/sterilizing the 
masks retains their cleanliness, their filtration capabilities and their 
breathability. However, the R function is lost in the cleaning process. 
This does not detract from the function of the masks in a domestic usage, 
but requires a modified usage of reused masks in the hospital environ-
ment. Although reused masks can no longer be used appropriately where 
blood or bodily fluid splashing can occur, such as in operating rooms, 
the reused masks can be used appropriately in other areas of the hos-
pital. It is important to note that in any case type IIR masks are already 
dedicated to operating rooms. 
The cleanliness of the masks is obtained by washing. This washing 
step is mandatory to respect good hygiene practice before any other 
treatment and acceptability for the user. The aim of the washing step is 
to eliminate all traces of biological contamination (secretions, mucus) 
and to lower the level of initial contamination (due to the 12min contact 
with disinfectant). Moreover, it tackles a large part of the problem of 
wearing a mask that is not your own. Indeed, even if a mask is sterilized, 
it is difficult to wear a used dirty mask that has not been washed. The 
SARS-CoV-2 is a virus sensitive to the combined action of detergents, 
mechanical movements and heat which occur in a washing machine. 
The commonly accepted recommendation for cloth-tissue mask is a 
washing step at 60 ◦C, or even lower (FNAM, 2020). As recommended 
for community use of masks, a sterilization step described in SI-2c is not 
recommended. 
The results of excellent FE remaining after even 10 cycles of washing 
has very positive sanitary consequences on the wearing of used/washed 
masks in the domestic environment, especially in the context of severe 
constraints on mask shortage or indeed the reduction of discarded 
single-usage masks on the environment. 
4.2. Collective treatment of the masks needs a sterilization step 
Mask reuse in a collective reprocessing generates more complexity, 
taking into account good hygiene practice and healthcare waste man-
agement. Although Kane et al., 2018, describe that “introducing circular 
economy principles into design for healthcare is challenging”, it is 
nonetheless an important point to address. It is critically important to 
consider the bacterial and fungal cleanliness of the recycled masks used 
in a healthcare environment. It is indeed required to eliminate all po-
tential risks of bacterial or fungal cross-contamination of masks poten-
tially exposed to microbiological agents of the wearer or of its 
environment. 
The 4 log10 spores reduction obtained with washing is in accordance 
with an experiment performed in Bangkok’s hospital (Luksamijarulkul 
et al., 2014), which evaluates the bacterial and fungal contamination on 
used medical masks worn by the HCW. The authors collected 230 used 
masks from 214 HCW and found that the maximal bioburden was less 
than 103 CFU/mL/piece on the outside area of the masks and less than 
102 CFU/mL/piece in the inside area of the masks (p < 0.001). In 
principle, this first washing step should be sufficient to eliminate the 
microorganisms that are present on the masks. Nonetheless, in the 
special case of a pandemic, especially for a virus pandemic, it is 
important to reduce the contamination risk to ensure a health and safety 
state (Bernard et al., 2020). Moreover, the analysis of the variability of 
the cleanliness of washed masks suggest that a safety state is not ach-
ieved by a washing step procedure using masks coming from the hos-
pital. The issue can also come from organisms that can be found in a 
hospital: Hepatitis B Virus or Mycobacterium tuberculosis are also ther-
moresistant up to 80–100 ◦C (Doig et al., 2002, König et al., 2019). Thus, 
other methods have to be applied after the washing process to ensure a 
perfect recycling quality. 
The reuse of cleaned mask is somehow not sufficient to provide 
enough safety for HCW and a sterilization step is mandatory, not to have 
a sterile status of the device but to minimize this risk of cross- 
contamination of resistant germs like spores or mycobacteria. The 
existing circuits of sterilization process of autoclavable tools and dirty 
laundry transfer circuit (Fig. 3) greatly facilitated the operating pro-
cedure in a healthcare environment. 
The industrial sector can also consider a collective recycling. Some 
companies have already shown a willingness to make progress in the 
ecological consequences of polypropylene recycling by creating specific 
recycling branches dedicated to medical masks. Despite those good in-
tentions, those small number of companies do not have sufficient 
financial resources to expand those recycling activities. Nonetheless, 
those examples add value to the global waste management, because 
before the masks are either discarded or recycled they are first reused. 
The risk of cross contamination in the industrial sector is often less 
present than in hospitals and the washing step is probably enough to 
guarantee the safety. This risk can be evaluated on a case-by-case base. 
However, the possibility of sterilizing is still possible with access to 
different technology platforms described in Table 3. 
The presence of autoclaves in sterilizing unit facilitates this process 
but the major drawback is the number of units that can be treated at the 
same time. The β and γ technologies have some differences in the pro-
cess. Gamma ray technologies make it possible to deliver the dose to a 
large volume of masks but slowly, while electron beam technologies, on 
the other hand, make it possible to achieve the same dose in a fraction of 
a second, but in a smaller volume. The net result is that β and γ tech-
nologies are comparable in processing capacity. Density is also a rele-
vant factor that influences on the penetration of radiation, and thus on 
the processing capacity. At this stage of the study, there will be no 
noticeable difference between β and γ radiation because the number of 
masks was small. They were wrapped into vacuum bag to reduce the 
thickness of each bag (more than one half-volume reduction), allowing 
the handling and the cleanliness of the masks until their reuse. A per-
formance qualification study will have to be carried out in each case 
when the process will be industrialised. 
EO treatment and irradiation treatments β and γ are cold sterilization 
alternative techniques to autoclave treatment. Despite the fact that the 
logistics have to be created unlike the washing/autoclave circuit, they 
are useful tools to process a huge quantity of masks at the same time in a 
single run. Supercritical carbon dioxyde-based treatments have very 
recently been successfully designed to allow cleaning and sterilization of 
medical masks or even Filtering Face-Piece respirators (N95/FFP2) 
(Cario et al., 2021). 
4.3. Biocompatibility preliminary data 
The results of FTIR and SEM analyses performed on the treated masks 
are very reassuring: they tend to indicate that the treatment yields no 
major modification of the physico-chemical components of the masks. 
Besides, most of the reusable cloth-tissue masks contain as much poly-
propylene as medical masks, and are certified for reuse after between 10 
and 50 washing cycles. No adverse event related to wearing washed 
cloth-tissue masks was reported, although millions of such masks were 
washed and reused all over the world. Therefore, demonstrating 
biocompatibility will be necessary only for manufacturers wishing to 
demonstrate full consistence to EN 14683 of washed masks. 
4.4. The conformity with the French standardization association 
(AFNOR) SPEC S76-001: 2020 allows not only to issue recommendations 
for the public, but also to perform a clinical trial in real conditions 
The washing conditions for reusable cloth-tissue masks are described 
in similar rules for each country (FNAMHPS, 2020 for France). Our 
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washing conditions were more demanding (60 ◦C instead of 40 ◦C). The 
conformity according to the French AFNOR SPEC S76-001: 2020 for 
cloth-tissue masks of 3 brands of medical masks washed up to 10 times 
under these conditions has been checked with success by independent 
certified actors (SI-7). This conformity, in accordance with European 
CWA 17553:2020 and US F2299/F2299M − 03 regulations, allows to 
recommend the reuse of washed medical masks instead of cloth-tissue 
masks to guarantee a higher level of filtration. Indeed, the quantity of 
3 μm particles emitted towards the entourage of a person in 6 min 
without any face protection is equivalent to the quantity emitted in 1 h 
with a 90% filtering cloth-tissue mask or in 5 h with a medical face mask 
filtering at 98% (SI-0). 
The loss of the CE marking led to the loss of legal status for the 
treated masks (which are non-reusable Medical Devices). A legal status 
is recovered by the AFNOR certification that will allow to test wearing/ 
treatment cycles in a future clinical trial. The main objective of this 
clinical trial will be to demonstrate that at least 10 cycles of use/washing 
and at least 5 cycles of use/washing/sterilization can be done in real 
conditions with full compatibility with EN14683 norm (including 
complete test of biocompatibility, which as previously discussed was not 
completely tested in the present work). 
4.5. Mask end of life 
The major issue is the limit of cycles that can be done. We arbitrarily 
stopped after 10 cycles of washing, which preserves the filtration 
properties of the masks. The number of cycle treatments will depend on 
wearing, washing and storing conditions. How to know when the mask is 
no more useable? The answer is probably “when it does not fit well to the 
face”. This answer is due to several reasons. First of all, the structure of 
the mask: each layer is a non-woven material. When a cut in the fibres 
occurs, the thread is not uncoiled. Holes or notches in a cloth-tissue 
mask, which are woven or knitted, will have a devastating effect on 
the filtration. Secondly, the 3 layers of material can slide one on the 
other and this phenomenon plugs cracks or holes so that the filtration 
capability is maintained, as shown in Fig. 3b. Finally, the most fragile 
parts of the mask are actually the nasal bar, the ear loop elastic band and 
especially their welding spot on the corners of the mask. The accumu-
lation of lint can be observed after several washes at home with short cut 
fibres going out of the mask outside layers. This pilling leads to un-
comfortable wear and can define the end of life of the mask even if 
filtration properties remain efficient. 
4.6. Economic perspective 
The reuse of medical mask opens new perspectives. The mask reuse 
has also a significant economical effect on households: The price of a 
tissue mask, with a guarantee of 50 washes, can reach up to 50 times the 
price of a medical mask. Thus, a medical mask washed 10 times is 10 
times cheaper. The cost of washing is zero has the masks are washed 
with the washing of domestic clothes. 
In collective treatment, the recycling price has to be evaluated ac-
cording to the number of masks used per day, the presence of a recycling 
process or the strategic partnership with appropriate companies. 
4.7. Ecologic perspectives 
Covid-19 pandemic has led to a widespread of environmental 
contamination of plastics, comprising the polypropylene medical masks. 
At a large scale or in highly specific environment, the low cost of 
disposable masks compared to the cost of recycling its polypropylene is 
probably not a viable economical target, because of the low weight/ 
volume of each mask, its infectious risk and the lack of existing recycling 
circuit. However, the ecological cost will more expensive at the end-of- 
mask-life. The rational reuse of medical mask and their end-of-live 
management is critical, particularly in pandemic periods when deci-
sive turns can be taken. The reuse is the first step of a recycling process. 
The use of disposable masks in the general population gives rise to 
Fig. 3. Waste management. Existing circuit (blue and grey, on left). Masks Reuse and Recycling circuit (green, on right). (For interpretation of the references to 
colour in this figure legend, the reader is referred to the Web version of this article.) 
Table 3 
Comparison of different treatments capacity and duration for medical mask reuse in collective settings.  
Methods Washing Autoclave β Radiations γ Radiations Ethylene oxide 
Location Hospital Hospital IONISOS CEA/IONISOS IONISOS 
Number of treated masks/cycle 5000 1200 170 000 >1 million up to 1 million 
Conditions Detergent 121 ◦C/20 min. 25 kGy vacuum 25 kGy vacuum 850 mg/L-40◦C-65% RH/12 h 
+disinfectant 
+60 ◦C/12 min 
Treatment duration 2 h 7 h <1 h 12 h 60 h 
Estimated global recycling time (including transport) 1 day 3 days 3 days 6 days  
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their larger consumption to help fight high transmissible mutants but 
their reuse up to 10 times will compensate or will even reduce their 
environmental impact. For lower scale uses, the possibility to safely 
recycle medical masks is cost-effective, and an eco-friendly gesture. 
Ecological consequences must be taken into account: a non-woven 
mask is easily recycled as it is only composed of pure polypropylene 
when the nasal bar and the elastic bands are removed. This is not the 
case for woven masks that often uses a mix of synthetic fibres and has to 
follow a specific recycling. However, the recycling of domestic usage of 
medical masks has not been yet envisaged. 
5. Conclusion 
We have proven that the lifetime of type II medical face masks can be 
extended by reusing them after washing and decontaminating treat-
ments. Those treatments consist in washing steps and/or washing ster-
ilizing cycles. The use of a detergent and a disinfectant during the 
washing step allows not only to clean the device but also to reduce the 
presence of germs. The masks retain their breathability and their 
filtration capability up to 10 cycles of washing or 5 washing cycles fol-
lowed by 5 autoclaving cycles without major structural and chemical 
modifications. Cold sterilizations, like radiations or EO treatment have 
also been tested with success. These experiments prove that those 
“disposable” masks remain reusable, with the exception of the anti- 
projection resistance that is not conserved, so that the masks cannot 
be reused in operating rooms. As washed medical masks remain more 
efficient in terms of filtration than cloth-tissue masks, we can recom-
mend their reuse according to the cloth-tissue mask regulations. A 
clinical trial in real conditions with full compliance with EN 14683 norm 
will allow the manufacturers to claim that type II medical face masks can 
be considered as Medical Devices after washing (followed or not by a 
sterilization process). This will require modifications of laws and regu-
lations in countries like France, where legal prohibitions prevent any 
reuse of a “single-use” Medical Device. However, we have demonstrated 
here that type II medical face masks are compliant with the regulations 
applicable for reusable cloth-tissue masks. This may have a tremendous 
impact in terms of public health and ecology. In terms of public health, 
wearing a type II medical face mask provides a much better protection 
than a cloth-tissue mask. In terms of ecology, reusing 10 times a type II 
medical face mask would reduce the burden associated with the waste 
management and the consumption of polypropylene. 
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Jérémy Herman, Laure Caillard, Stéphane Lemasson for availability and 
mask collection and washing. We thank Patrick Meresse and his CUBE 
for petri dishes donation. 
Appendix A. Supplementary data 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.chemosphere.2021.132364. 
Funding information 
This study has been carried out in the framework of a French sci-
entific consortium initiated by Centre national de la recherche scienti-
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